Global Amyotrophic Lateral Sclerosis Gene Testing Market Growth (Status and Outlook) 2026-2032
The global Amyotrophic Lateral Sclerosis Gene Testing market size is predicted to grow from US$ 132 million in 2025 to US$ 221 million in 2032; it is expected to grow at a CAGR of 7.8% from 2026 to 2032.
Amyotrophic Lateral Sclerosis (ALS) Gene Testing is a molecular diagnostic technology used to identify whether an individual carries mutations associated with ALS. ALS is a neurodegenerative disorder that primarily affects motor neurons, resulting in muscle weakness, atrophy, and loss of motor function. Gene testing employs high-throughput sequencing, single nucleotide polymorphism (SNP) analysis, and targeted gene capture methods to detect mutations in known ALS-related genes, such as C9orf72, SOD1, TARDBP, and FUS. This technology provides a scientific basis for early clinical diagnosis, family genetic risk assessment, and personalized treatment planning, while also supporting novel targeted therapy development, drug screening, and clinical trial enrollment. With the advancement of precision medicine, ALS gene testing is evolving toward higher sensitivity, broader coverage, and automated data analysis.The average gross profit margin of this product is 45%.
The ALS gene testing market is growing rapidly due to increasing demand for neurodegenerative disease diagnostics and the adoption of precision medicine. Early diagnosis and familial ALS risk assessment drive clinical testing demand, while research institutions and pharmaceutical companies’ reliance on genetic data promotes the application of testing technologies. The maturity of high-throughput sequencing, targeted capture techniques, and bioinformatics platforms has enhanced sensitivity and coverage, providing strong technical support for clinical and research applications. Government support for rare and genetic diseases, along with growing patient awareness of early intervention and personalized treatment, also serve as key market growth drivers.ALS gene testing faces challenges such as high costs, lack of standardized testing protocols, and complex data interpretation. Different laboratory platforms and methods may lead to result variability, complicating clinical decision-making. The phenotypic heterogeneity and incomplete penetrance of ALS gene mutations introduce uncertainty in clinical applications. Furthermore, data privacy and ethical concerns, particularly regarding familial genetic information, impose additional requirements on the industry. Limited public awareness and restricted insurance coverage also constrain the widespread adoption of testing.
Downstream demand is increasingly focused on early diagnosis, risk prediction, and personalized intervention strategies. Clinical institutions, genetic counseling centers, and research organizations are expanding their use of ALS gene testing to support clinical decision-making and new drug development. The reliance of drug development and clinical trials on patient genotyping and precision enrollment further drives commercialization of testing services. As gene testing becomes more widespread, patient and family awareness of risk assessment and preventive interventions is rising, promoting the integration of genetic testing with health management.Upstream raw materials for ALS gene testing include high-throughput sequencing reagents, capture probes, PCR reagents, library preparation kits, and data analysis software and servers. The quality of sequencing chips and capture probes directly impacts test accuracy and coverage, representing core technical components. Major suppliers are concentrated in Europe, North America, and parts of the Asia-Pacific region, with mature production systems and quality control capabilities. Advances in biotechnology have improved reagent stability, automation, and data analysis capabilities, providing reliable support and efficient production for testing.
This Insight Report provides a comprehensive analysis of the global Amyotrophic Lateral Sclerosis Gene Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Amyotrophic Lateral Sclerosis Gene Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Amyotrophic Lateral Sclerosis Gene Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Amyotrophic Lateral Sclerosis Gene Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Amyotrophic Lateral Sclerosis Gene Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Amyotrophic Lateral Sclerosis Gene Testing market by product type, application, key players and key regions and countries.
Amyotrophic Lateral Sclerosis (ALS) Gene Testing is a molecular diagnostic technology used to identify whether an individual carries mutations associated with ALS. ALS is a neurodegenerative disorder that primarily affects motor neurons, resulting in muscle weakness, atrophy, and loss of motor function. Gene testing employs high-throughput sequencing, single nucleotide polymorphism (SNP) analysis, and targeted gene capture methods to detect mutations in known ALS-related genes, such as C9orf72, SOD1, TARDBP, and FUS. This technology provides a scientific basis for early clinical diagnosis, family genetic risk assessment, and personalized treatment planning, while also supporting novel targeted therapy development, drug screening, and clinical trial enrollment. With the advancement of precision medicine, ALS gene testing is evolving toward higher sensitivity, broader coverage, and automated data analysis.The average gross profit margin of this product is 45%.
The ALS gene testing market is growing rapidly due to increasing demand for neurodegenerative disease diagnostics and the adoption of precision medicine. Early diagnosis and familial ALS risk assessment drive clinical testing demand, while research institutions and pharmaceutical companies’ reliance on genetic data promotes the application of testing technologies. The maturity of high-throughput sequencing, targeted capture techniques, and bioinformatics platforms has enhanced sensitivity and coverage, providing strong technical support for clinical and research applications. Government support for rare and genetic diseases, along with growing patient awareness of early intervention and personalized treatment, also serve as key market growth drivers.ALS gene testing faces challenges such as high costs, lack of standardized testing protocols, and complex data interpretation. Different laboratory platforms and methods may lead to result variability, complicating clinical decision-making. The phenotypic heterogeneity and incomplete penetrance of ALS gene mutations introduce uncertainty in clinical applications. Furthermore, data privacy and ethical concerns, particularly regarding familial genetic information, impose additional requirements on the industry. Limited public awareness and restricted insurance coverage also constrain the widespread adoption of testing.
Downstream demand is increasingly focused on early diagnosis, risk prediction, and personalized intervention strategies. Clinical institutions, genetic counseling centers, and research organizations are expanding their use of ALS gene testing to support clinical decision-making and new drug development. The reliance of drug development and clinical trials on patient genotyping and precision enrollment further drives commercialization of testing services. As gene testing becomes more widespread, patient and family awareness of risk assessment and preventive interventions is rising, promoting the integration of genetic testing with health management.Upstream raw materials for ALS gene testing include high-throughput sequencing reagents, capture probes, PCR reagents, library preparation kits, and data analysis software and servers. The quality of sequencing chips and capture probes directly impacts test accuracy and coverage, representing core technical components. Major suppliers are concentrated in Europe, North America, and parts of the Asia-Pacific region, with mature production systems and quality control capabilities. Advances in biotechnology have improved reagent stability, automation, and data analysis capabilities, providing reliable support and efficient production for testing.
Report Scope
LPI (LP Information)' newest research report, the “Amyotrophic Lateral Sclerosis Gene Testing Industry Forecast” looks at past sales and reviews total world Amyotrophic Lateral Sclerosis Gene Testing sales in 2025, providing a comprehensive analysis by region and market sector of projected Amyotrophic Lateral Sclerosis Gene Testing sales for 2026 through 2032. With Amyotrophic Lateral Sclerosis Gene Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Amyotrophic Lateral Sclerosis Gene Testing industry.This Insight Report provides a comprehensive analysis of the global Amyotrophic Lateral Sclerosis Gene Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Amyotrophic Lateral Sclerosis Gene Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Amyotrophic Lateral Sclerosis Gene Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Amyotrophic Lateral Sclerosis Gene Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Amyotrophic Lateral Sclerosis Gene Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Amyotrophic Lateral Sclerosis Gene Testing market by product type, application, key players and key regions and countries.
Market Segmentation
Segmentation by Type:
- Targeted ALS Gene Panel
- Single-Gene
- Whole Exome Sequencing
- Whole Genome Sequencing
Segmentation by Product Type:
- IVD Kits
- Diagnostic Instruments
- Other
Segmentation by Sample:
- Blood/Serum
- Saliva
- Other
Segmentation by Application:
- Hospitals
- Third-party Laboratory
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Invitae
- Quest Diagnostics
- Labcorp
- GeneDx
- Centogene
- Fulgent Genetics
- Ambry Genetics
- Baylor Genetics
- Mayo Clinic Laboratories
- NEALS Consortium Labs
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Amyotrophic Lateral Sclerosis Gene Testing Market Size (2021-2032)
2.1.2 Amyotrophic Lateral Sclerosis Gene Testing Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Amyotrophic Lateral Sclerosis Gene Testing by Country/Region (2021, 2025 & 2032)
2.2 Amyotrophic Lateral Sclerosis Gene Testing Segment by Type
2.2.1 Targeted ALS Gene Panel
2.2.2 Single-Gene
2.2.3 Whole Exome Sequencing
2.2.4 Whole Genome Sequencing
2.2.5 Amyotrophic Lateral Sclerosis Gene Testing Market Size by Type
2.2.5.1 Amyotrophic Lateral Sclerosis Gene Testing Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Type (2021-2026)
2.3 Amyotrophic Lateral Sclerosis Gene Testing Segment by Product Type
2.3.1 IVD Kits
2.3.2 Diagnostic Instruments
2.3.3 Other
2.3.4 Amyotrophic Lateral Sclerosis Gene Testing Market Size by Product Type
2.3.4.1 Amyotrophic Lateral Sclerosis Gene Testing Market Size CAGR by Product Type (2021 VS 2025 VS 2032)
2.3.4.2 Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Product Type (2021-2026)
2.4 Amyotrophic Lateral Sclerosis Gene Testing Segment by Sample
2.4.1 Blood/Serum
2.4.2 Saliva
2.4.3 Other
2.4.4 Amyotrophic Lateral Sclerosis Gene Testing Market Size by Sample
2.4.4.1 Amyotrophic Lateral Sclerosis Gene Testing Market Size CAGR by Sample (2021 VS 2025 VS 2032)
2.4.4.2 Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Sample (2021-2026)
2.5 Amyotrophic Lateral Sclerosis Gene Testing Segment by Application
2.5.1 Hospitals
2.5.2 Third-party Laboratory
2.5.3 Others
2.5.4 Amyotrophic Lateral Sclerosis Gene Testing Market Size by Application
2.5.4.1 Amyotrophic Lateral Sclerosis Gene Testing Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Application (2021-2026)
3 AMYOTROPHIC LATERAL SCLEROSIS GENE TESTING MARKET SIZE BY PLAYER
3.1 Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Player
3.1.1 Global Amyotrophic Lateral Sclerosis Gene Testing Revenue by Player (2021-2026)
3.1.2 Global Amyotrophic Lateral Sclerosis Gene Testing Revenue Market Share by Player (2021-2026)
3.2 Global Amyotrophic Lateral Sclerosis Gene Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AMYOTROPHIC LATERAL SCLEROSIS GENE TESTING BY REGION
4.1 Amyotrophic Lateral Sclerosis Gene Testing Market Size by Region (2021-2026)
4.2 Global Amyotrophic Lateral Sclerosis Gene Testing Annual Revenue by Country/Region (2021-2026)
4.3 Americas Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth (2021-2026)
4.4 APAC Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth (2021-2026)
4.5 Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth (2021-2026)
4.6 Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Amyotrophic Lateral Sclerosis Gene Testing Market Size by Country (2021-2026)
5.2 Americas Amyotrophic Lateral Sclerosis Gene Testing Market Size by Type (2021-2026)
5.3 Americas Amyotrophic Lateral Sclerosis Gene Testing Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Amyotrophic Lateral Sclerosis Gene Testing Market Size by Region (2021-2026)
6.2 APAC Amyotrophic Lateral Sclerosis Gene Testing Market Size by Type (2021-2026)
6.3 APAC Amyotrophic Lateral Sclerosis Gene Testing Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size by Country (2021-2026)
7.2 Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size by Type (2021-2026)
7.3 Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing by Region (2021-2026)
8.2 Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size by Type (2021-2026)
8.3 Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AMYOTROPHIC LATERAL SCLEROSIS GENE TESTING MARKET FORECAST
10.1 Global Amyotrophic Lateral Sclerosis Gene Testing Forecast by Region (2027-2032)
10.1.1 Global Amyotrophic Lateral Sclerosis Gene Testing Forecast by Region (2027-2032)
10.1.2 Americas Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.1.3 APAC Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.1.4 Europe Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.1.5 Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.2 Americas Amyotrophic Lateral Sclerosis Gene Testing Forecast by Country (2027-2032)
10.2.1 United States Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.2.2 Canada Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.2.3 Mexico Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.2.4 Brazil Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.3 APAC Amyotrophic Lateral Sclerosis Gene Testing Forecast by Region (2027-2032)
10.3.1 China Amyotrophic Lateral Sclerosis Gene Testing Market Forecast
10.3.2 Japan Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.3.3 Korea Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.3.4 Southeast Asia Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.3.5 India Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.3.6 Australia Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.4 Europe Amyotrophic Lateral Sclerosis Gene Testing Forecast by Country (2027-2032)
10.4.1 Germany Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.4.2 France Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.4.3 UK Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.4.4 Italy Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.4.5 Russia Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.5 Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Forecast by Region (2027-2032)
10.5.1 Egypt Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.5.2 South Africa Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.5.3 Israel Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.5.4 Turkey Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.6 Global Amyotrophic Lateral Sclerosis Gene Testing Forecast by Type (2027-2032)
10.7 Global Amyotrophic Lateral Sclerosis Gene Testing Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
11 KEY PLAYERS ANALYSIS
11.1 Invitae
11.1.1 Invitae Company Information
11.1.2 Invitae Amyotrophic Lateral Sclerosis Gene Testing Product Offered
11.1.3 Invitae Amyotrophic Lateral Sclerosis Gene Testing Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Invitae Main Business Overview
11.1.5 Invitae Latest Developments
11.2 Quest Diagnostics
11.2.1 Quest Diagnostics Company Information
11.2.2 Quest Diagnostics Amyotrophic Lateral Sclerosis Gene Testing Product Offered
11.2.3 Quest Diagnostics Amyotrophic Lateral Sclerosis Gene Testing Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Quest Diagnostics Main Business Overview
11.2.5 Quest Diagnostics Latest Developments
11.3 Labcorp
11.3.1 Labcorp Company Information
11.3.2 Labcorp Amyotrophic Lateral Sclerosis Gene Testing Product Offered
11.3.3 Labcorp Amyotrophic Lateral Sclerosis Gene Testing Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Labcorp Main Business Overview
11.3.5 Labcorp Latest Developments
11.4 GeneDx
11.4.1 GeneDx Company Information
11.4.2 GeneDx Amyotrophic Lateral Sclerosis Gene Testing Product Offered
11.4.3 GeneDx Amyotrophic Lateral Sclerosis Gene Testing Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 GeneDx Main Business Overview
11.4.5 GeneDx Latest Developments
11.5 Centogene
11.5.1 Centogene Company Information
11.5.2 Centogene Amyotrophic Lateral Sclerosis Gene Testing Product Offered
11.5.3 Centogene Amyotrophic Lateral Sclerosis Gene Testing Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Centogene Main Business Overview
11.5.5 Centogene Latest Developments
11.6 Fulgent Genetics
11.6.1 Fulgent Genetics Company Information
11.6.2 Fulgent Genetics Amyotrophic Lateral Sclerosis Gene Testing Product Offered
11.6.3 Fulgent Genetics Amyotrophic Lateral Sclerosis Gene Testing Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Fulgent Genetics Main Business Overview
11.6.5 Fulgent Genetics Latest Developments
11.7 Ambry Genetics
11.7.1 Ambry Genetics Company Information
11.7.2 Ambry Genetics Amyotrophic Lateral Sclerosis Gene Testing Product Offered
11.7.3 Ambry Genetics Amyotrophic Lateral Sclerosis Gene Testing Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Ambry Genetics Main Business Overview
11.7.5 Ambry Genetics Latest Developments
11.8 Baylor Genetics
11.8.1 Baylor Genetics Company Information
11.8.2 Baylor Genetics Amyotrophic Lateral Sclerosis Gene Testing Product Offered
11.8.3 Baylor Genetics Amyotrophic Lateral Sclerosis Gene Testing Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Baylor Genetics Main Business Overview
11.8.5 Baylor Genetics Latest Developments
11.9 Mayo Clinic Laboratories
11.9.1 Mayo Clinic Laboratories Company Information
11.9.2 Mayo Clinic Laboratories Amyotrophic Lateral Sclerosis Gene Testing Product Offered
11.9.3 Mayo Clinic Laboratories Amyotrophic Lateral Sclerosis Gene Testing Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Mayo Clinic Laboratories Main Business Overview
11.9.5 Mayo Clinic Laboratories Latest Developments
11.10 NEALS Consortium Labs
11.10.1 NEALS Consortium Labs Company Information
11.10.2 NEALS Consortium Labs Amyotrophic Lateral Sclerosis Gene Testing Product Offered
11.10.3 NEALS Consortium Labs Amyotrophic Lateral Sclerosis Gene Testing Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 NEALS Consortium Labs Main Business Overview
11.10.5 NEALS Consortium Labs Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Amyotrophic Lateral Sclerosis Gene Testing Market Size (2021-2032)
2.1.2 Amyotrophic Lateral Sclerosis Gene Testing Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Amyotrophic Lateral Sclerosis Gene Testing by Country/Region (2021, 2025 & 2032)
2.2 Amyotrophic Lateral Sclerosis Gene Testing Segment by Type
2.2.1 Targeted ALS Gene Panel
2.2.2 Single-Gene
2.2.3 Whole Exome Sequencing
2.2.4 Whole Genome Sequencing
2.2.5 Amyotrophic Lateral Sclerosis Gene Testing Market Size by Type
2.2.5.1 Amyotrophic Lateral Sclerosis Gene Testing Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Type (2021-2026)
2.3 Amyotrophic Lateral Sclerosis Gene Testing Segment by Product Type
2.3.1 IVD Kits
2.3.2 Diagnostic Instruments
2.3.3 Other
2.3.4 Amyotrophic Lateral Sclerosis Gene Testing Market Size by Product Type
2.3.4.1 Amyotrophic Lateral Sclerosis Gene Testing Market Size CAGR by Product Type (2021 VS 2025 VS 2032)
2.3.4.2 Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Product Type (2021-2026)
2.4 Amyotrophic Lateral Sclerosis Gene Testing Segment by Sample
2.4.1 Blood/Serum
2.4.2 Saliva
2.4.3 Other
2.4.4 Amyotrophic Lateral Sclerosis Gene Testing Market Size by Sample
2.4.4.1 Amyotrophic Lateral Sclerosis Gene Testing Market Size CAGR by Sample (2021 VS 2025 VS 2032)
2.4.4.2 Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Sample (2021-2026)
2.5 Amyotrophic Lateral Sclerosis Gene Testing Segment by Application
2.5.1 Hospitals
2.5.2 Third-party Laboratory
2.5.3 Others
2.5.4 Amyotrophic Lateral Sclerosis Gene Testing Market Size by Application
2.5.4.1 Amyotrophic Lateral Sclerosis Gene Testing Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Application (2021-2026)
3 AMYOTROPHIC LATERAL SCLEROSIS GENE TESTING MARKET SIZE BY PLAYER
3.1 Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Player
3.1.1 Global Amyotrophic Lateral Sclerosis Gene Testing Revenue by Player (2021-2026)
3.1.2 Global Amyotrophic Lateral Sclerosis Gene Testing Revenue Market Share by Player (2021-2026)
3.2 Global Amyotrophic Lateral Sclerosis Gene Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AMYOTROPHIC LATERAL SCLEROSIS GENE TESTING BY REGION
4.1 Amyotrophic Lateral Sclerosis Gene Testing Market Size by Region (2021-2026)
4.2 Global Amyotrophic Lateral Sclerosis Gene Testing Annual Revenue by Country/Region (2021-2026)
4.3 Americas Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth (2021-2026)
4.4 APAC Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth (2021-2026)
4.5 Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth (2021-2026)
4.6 Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Amyotrophic Lateral Sclerosis Gene Testing Market Size by Country (2021-2026)
5.2 Americas Amyotrophic Lateral Sclerosis Gene Testing Market Size by Type (2021-2026)
5.3 Americas Amyotrophic Lateral Sclerosis Gene Testing Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Amyotrophic Lateral Sclerosis Gene Testing Market Size by Region (2021-2026)
6.2 APAC Amyotrophic Lateral Sclerosis Gene Testing Market Size by Type (2021-2026)
6.3 APAC Amyotrophic Lateral Sclerosis Gene Testing Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size by Country (2021-2026)
7.2 Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size by Type (2021-2026)
7.3 Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing by Region (2021-2026)
8.2 Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size by Type (2021-2026)
8.3 Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AMYOTROPHIC LATERAL SCLEROSIS GENE TESTING MARKET FORECAST
10.1 Global Amyotrophic Lateral Sclerosis Gene Testing Forecast by Region (2027-2032)
10.1.1 Global Amyotrophic Lateral Sclerosis Gene Testing Forecast by Region (2027-2032)
10.1.2 Americas Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.1.3 APAC Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.1.4 Europe Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.1.5 Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.2 Americas Amyotrophic Lateral Sclerosis Gene Testing Forecast by Country (2027-2032)
10.2.1 United States Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.2.2 Canada Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.2.3 Mexico Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.2.4 Brazil Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.3 APAC Amyotrophic Lateral Sclerosis Gene Testing Forecast by Region (2027-2032)
10.3.1 China Amyotrophic Lateral Sclerosis Gene Testing Market Forecast
10.3.2 Japan Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.3.3 Korea Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.3.4 Southeast Asia Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.3.5 India Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.3.6 Australia Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.4 Europe Amyotrophic Lateral Sclerosis Gene Testing Forecast by Country (2027-2032)
10.4.1 Germany Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.4.2 France Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.4.3 UK Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.4.4 Italy Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.4.5 Russia Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.5 Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Forecast by Region (2027-2032)
10.5.1 Egypt Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.5.2 South Africa Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.5.3 Israel Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.5.4 Turkey Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
10.6 Global Amyotrophic Lateral Sclerosis Gene Testing Forecast by Type (2027-2032)
10.7 Global Amyotrophic Lateral Sclerosis Gene Testing Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Amyotrophic Lateral Sclerosis Gene Testing Forecast
11 KEY PLAYERS ANALYSIS
11.1 Invitae
11.1.1 Invitae Company Information
11.1.2 Invitae Amyotrophic Lateral Sclerosis Gene Testing Product Offered
11.1.3 Invitae Amyotrophic Lateral Sclerosis Gene Testing Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Invitae Main Business Overview
11.1.5 Invitae Latest Developments
11.2 Quest Diagnostics
11.2.1 Quest Diagnostics Company Information
11.2.2 Quest Diagnostics Amyotrophic Lateral Sclerosis Gene Testing Product Offered
11.2.3 Quest Diagnostics Amyotrophic Lateral Sclerosis Gene Testing Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Quest Diagnostics Main Business Overview
11.2.5 Quest Diagnostics Latest Developments
11.3 Labcorp
11.3.1 Labcorp Company Information
11.3.2 Labcorp Amyotrophic Lateral Sclerosis Gene Testing Product Offered
11.3.3 Labcorp Amyotrophic Lateral Sclerosis Gene Testing Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Labcorp Main Business Overview
11.3.5 Labcorp Latest Developments
11.4 GeneDx
11.4.1 GeneDx Company Information
11.4.2 GeneDx Amyotrophic Lateral Sclerosis Gene Testing Product Offered
11.4.3 GeneDx Amyotrophic Lateral Sclerosis Gene Testing Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 GeneDx Main Business Overview
11.4.5 GeneDx Latest Developments
11.5 Centogene
11.5.1 Centogene Company Information
11.5.2 Centogene Amyotrophic Lateral Sclerosis Gene Testing Product Offered
11.5.3 Centogene Amyotrophic Lateral Sclerosis Gene Testing Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Centogene Main Business Overview
11.5.5 Centogene Latest Developments
11.6 Fulgent Genetics
11.6.1 Fulgent Genetics Company Information
11.6.2 Fulgent Genetics Amyotrophic Lateral Sclerosis Gene Testing Product Offered
11.6.3 Fulgent Genetics Amyotrophic Lateral Sclerosis Gene Testing Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Fulgent Genetics Main Business Overview
11.6.5 Fulgent Genetics Latest Developments
11.7 Ambry Genetics
11.7.1 Ambry Genetics Company Information
11.7.2 Ambry Genetics Amyotrophic Lateral Sclerosis Gene Testing Product Offered
11.7.3 Ambry Genetics Amyotrophic Lateral Sclerosis Gene Testing Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Ambry Genetics Main Business Overview
11.7.5 Ambry Genetics Latest Developments
11.8 Baylor Genetics
11.8.1 Baylor Genetics Company Information
11.8.2 Baylor Genetics Amyotrophic Lateral Sclerosis Gene Testing Product Offered
11.8.3 Baylor Genetics Amyotrophic Lateral Sclerosis Gene Testing Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Baylor Genetics Main Business Overview
11.8.5 Baylor Genetics Latest Developments
11.9 Mayo Clinic Laboratories
11.9.1 Mayo Clinic Laboratories Company Information
11.9.2 Mayo Clinic Laboratories Amyotrophic Lateral Sclerosis Gene Testing Product Offered
11.9.3 Mayo Clinic Laboratories Amyotrophic Lateral Sclerosis Gene Testing Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Mayo Clinic Laboratories Main Business Overview
11.9.5 Mayo Clinic Laboratories Latest Developments
11.10 NEALS Consortium Labs
11.10.1 NEALS Consortium Labs Company Information
11.10.2 NEALS Consortium Labs Amyotrophic Lateral Sclerosis Gene Testing Product Offered
11.10.3 NEALS Consortium Labs Amyotrophic Lateral Sclerosis Gene Testing Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 NEALS Consortium Labs Main Business Overview
11.10.5 NEALS Consortium Labs Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Amyotrophic Lateral Sclerosis Gene Testing Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Amyotrophic Lateral Sclerosis Gene Testing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Targeted ALS Gene Panel
Table 4. Major Players of Single-Gene
Table 5. Major Players of Whole Exome Sequencing
Table 6. Major Players of Whole Genome Sequencing
Table 7. Amyotrophic Lateral Sclerosis Gene Testing Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Type (2021-2026)
Table 10. Major Players of IVD Kits
Table 11. Major Players of Diagnostic Instruments
Table 12. Major Players of Other
Table 13. Amyotrophic Lateral Sclerosis Gene Testing Market Size CAGR by Product Type (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size by Product Type (2021-2026) & ($ millions)
Table 15. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Product Type (2021-2026)
Table 16. Major Players of Blood/Serum
Table 17. Major Players of Saliva
Table 18. Major Players of Other
Table 19. Amyotrophic Lateral Sclerosis Gene Testing Market Size CAGR by Sample (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size by Sample (2021-2026) & ($ millions)
Table 21. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Sample (2021-2026)
Table 22. Amyotrophic Lateral Sclerosis Gene Testing Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 23. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size by Application (2021-2026) & ($ millions)
Table 24. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Application (2021-2026)
Table 25. Global Amyotrophic Lateral Sclerosis Gene Testing Revenue by Player (2021-2026) & ($ millions)
Table 26. Global Amyotrophic Lateral Sclerosis Gene Testing Revenue Market Share by Player (2021-2026)
Table 27. Amyotrophic Lateral Sclerosis Gene Testing Key Players Head office and Products Offered
Table 28. Amyotrophic Lateral Sclerosis Gene Testing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size by Region (2021-2026) & ($ millions)
Table 32. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Region (2021-2026)
Table 33. Global Amyotrophic Lateral Sclerosis Gene Testing Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Amyotrophic Lateral Sclerosis Gene Testing Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Amyotrophic Lateral Sclerosis Gene Testing Market Size by Country (2021-2026) & ($ millions)
Table 36. Americas Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Country (2021-2026)
Table 37. Americas Amyotrophic Lateral Sclerosis Gene Testing Market Size by Type (2021-2026) & ($ millions)
Table 38. Americas Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Type (2021-2026)
Table 39. Americas Amyotrophic Lateral Sclerosis Gene Testing Market Size by Application (2021-2026) & ($ millions)
Table 40. Americas Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Application (2021-2026)
Table 41. APAC Amyotrophic Lateral Sclerosis Gene Testing Market Size by Region (2021-2026) & ($ millions)
Table 42. APAC Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Region (2021-2026)
Table 43. APAC Amyotrophic Lateral Sclerosis Gene Testing Market Size by Type (2021-2026) & ($ millions)
Table 44. APAC Amyotrophic Lateral Sclerosis Gene Testing Market Size by Application (2021-2026) & ($ millions)
Table 45. Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size by Country (2021-2026) & ($ millions)
Table 46. Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Country (2021-2026)
Table 47. Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size by Type (2021-2026) & ($ millions)
Table 48. Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size by Application (2021-2026) & ($ millions)
Table 49. Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size by Region (2021-2026) & ($ millions)
Table 50. Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size by Type (2021-2026) & ($ millions)
Table 51. Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size by Application (2021-2026) & ($ millions)
Table 52. Key Market Drivers & Growth Opportunities of Amyotrophic Lateral Sclerosis Gene Testing
Table 53. Key Market Challenges & Risks of Amyotrophic Lateral Sclerosis Gene Testing
Table 54. Key Industry Trends of Amyotrophic Lateral Sclerosis Gene Testing
Table 55. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Forecast by Region (2027-2032) & ($ millions)
Table 56. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share Forecast by Region (2027-2032)
Table 57. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Forecast by Type (2027-2032) & ($ millions)
Table 58. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Forecast by Application (2027-2032) & ($ millions)
Table 59. Invitae Details, Company Type, Amyotrophic Lateral Sclerosis Gene Testing Area Served and Its Competitors
Table 60. Invitae Amyotrophic Lateral Sclerosis Gene Testing Product Offered
Table 61. Invitae Amyotrophic Lateral Sclerosis Gene Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 62. Invitae Main Business
Table 63. Invitae Latest Developments
Table 64. Quest Diagnostics Details, Company Type, Amyotrophic Lateral Sclerosis Gene Testing Area Served and Its Competitors
Table 65. Quest Diagnostics Amyotrophic Lateral Sclerosis Gene Testing Product Offered
Table 66. Quest Diagnostics Amyotrophic Lateral Sclerosis Gene Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. Quest Diagnostics Main Business
Table 68. Quest Diagnostics Latest Developments
Table 69. Labcorp Details, Company Type, Amyotrophic Lateral Sclerosis Gene Testing Area Served and Its Competitors
Table 70. Labcorp Amyotrophic Lateral Sclerosis Gene Testing Product Offered
Table 71. Labcorp Amyotrophic Lateral Sclerosis Gene Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. Labcorp Main Business
Table 73. Labcorp Latest Developments
Table 74. GeneDx Details, Company Type, Amyotrophic Lateral Sclerosis Gene Testing Area Served and Its Competitors
Table 75. GeneDx Amyotrophic Lateral Sclerosis Gene Testing Product Offered
Table 76. GeneDx Amyotrophic Lateral Sclerosis Gene Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. GeneDx Main Business
Table 78. GeneDx Latest Developments
Table 79. Centogene Details, Company Type, Amyotrophic Lateral Sclerosis Gene Testing Area Served and Its Competitors
Table 80. Centogene Amyotrophic Lateral Sclerosis Gene Testing Product Offered
Table 81. Centogene Amyotrophic Lateral Sclerosis Gene Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. Centogene Main Business
Table 83. Centogene Latest Developments
Table 84. Fulgent Genetics Details, Company Type, Amyotrophic Lateral Sclerosis Gene Testing Area Served and Its Competitors
Table 85. Fulgent Genetics Amyotrophic Lateral Sclerosis Gene Testing Product Offered
Table 86. Fulgent Genetics Amyotrophic Lateral Sclerosis Gene Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. Fulgent Genetics Main Business
Table 88. Fulgent Genetics Latest Developments
Table 89. Ambry Genetics Details, Company Type, Amyotrophic Lateral Sclerosis Gene Testing Area Served and Its Competitors
Table 90. Ambry Genetics Amyotrophic Lateral Sclerosis Gene Testing Product Offered
Table 91. Ambry Genetics Amyotrophic Lateral Sclerosis Gene Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. Ambry Genetics Main Business
Table 93. Ambry Genetics Latest Developments
Table 94. Baylor Genetics Details, Company Type, Amyotrophic Lateral Sclerosis Gene Testing Area Served and Its Competitors
Table 95. Baylor Genetics Amyotrophic Lateral Sclerosis Gene Testing Product Offered
Table 96. Baylor Genetics Amyotrophic Lateral Sclerosis Gene Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. Baylor Genetics Main Business
Table 98. Baylor Genetics Latest Developments
Table 99. Mayo Clinic Laboratories Details, Company Type, Amyotrophic Lateral Sclerosis Gene Testing Area Served and Its Competitors
Table 100. Mayo Clinic Laboratories Amyotrophic Lateral Sclerosis Gene Testing Product Offered
Table 101. Mayo Clinic Laboratories Amyotrophic Lateral Sclerosis Gene Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 102. Mayo Clinic Laboratories Main Business
Table 103. Mayo Clinic Laboratories Latest Developments
Table 104. NEALS Consortium Labs Details, Company Type, Amyotrophic Lateral Sclerosis Gene Testing Area Served and Its Competitors
Table 105. NEALS Consortium Labs Amyotrophic Lateral Sclerosis Gene Testing Product Offered
Table 106. NEALS Consortium Labs Amyotrophic Lateral Sclerosis Gene Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 107. NEALS Consortium Labs Main Business
Table 108. NEALS Consortium Labs Latest Developments
Table 1. Amyotrophic Lateral Sclerosis Gene Testing Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Amyotrophic Lateral Sclerosis Gene Testing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Targeted ALS Gene Panel
Table 4. Major Players of Single-Gene
Table 5. Major Players of Whole Exome Sequencing
Table 6. Major Players of Whole Genome Sequencing
Table 7. Amyotrophic Lateral Sclerosis Gene Testing Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Type (2021-2026)
Table 10. Major Players of IVD Kits
Table 11. Major Players of Diagnostic Instruments
Table 12. Major Players of Other
Table 13. Amyotrophic Lateral Sclerosis Gene Testing Market Size CAGR by Product Type (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size by Product Type (2021-2026) & ($ millions)
Table 15. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Product Type (2021-2026)
Table 16. Major Players of Blood/Serum
Table 17. Major Players of Saliva
Table 18. Major Players of Other
Table 19. Amyotrophic Lateral Sclerosis Gene Testing Market Size CAGR by Sample (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size by Sample (2021-2026) & ($ millions)
Table 21. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Sample (2021-2026)
Table 22. Amyotrophic Lateral Sclerosis Gene Testing Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 23. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size by Application (2021-2026) & ($ millions)
Table 24. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Application (2021-2026)
Table 25. Global Amyotrophic Lateral Sclerosis Gene Testing Revenue by Player (2021-2026) & ($ millions)
Table 26. Global Amyotrophic Lateral Sclerosis Gene Testing Revenue Market Share by Player (2021-2026)
Table 27. Amyotrophic Lateral Sclerosis Gene Testing Key Players Head office and Products Offered
Table 28. Amyotrophic Lateral Sclerosis Gene Testing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size by Region (2021-2026) & ($ millions)
Table 32. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Region (2021-2026)
Table 33. Global Amyotrophic Lateral Sclerosis Gene Testing Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Amyotrophic Lateral Sclerosis Gene Testing Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Amyotrophic Lateral Sclerosis Gene Testing Market Size by Country (2021-2026) & ($ millions)
Table 36. Americas Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Country (2021-2026)
Table 37. Americas Amyotrophic Lateral Sclerosis Gene Testing Market Size by Type (2021-2026) & ($ millions)
Table 38. Americas Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Type (2021-2026)
Table 39. Americas Amyotrophic Lateral Sclerosis Gene Testing Market Size by Application (2021-2026) & ($ millions)
Table 40. Americas Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Application (2021-2026)
Table 41. APAC Amyotrophic Lateral Sclerosis Gene Testing Market Size by Region (2021-2026) & ($ millions)
Table 42. APAC Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Region (2021-2026)
Table 43. APAC Amyotrophic Lateral Sclerosis Gene Testing Market Size by Type (2021-2026) & ($ millions)
Table 44. APAC Amyotrophic Lateral Sclerosis Gene Testing Market Size by Application (2021-2026) & ($ millions)
Table 45. Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size by Country (2021-2026) & ($ millions)
Table 46. Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Country (2021-2026)
Table 47. Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size by Type (2021-2026) & ($ millions)
Table 48. Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size by Application (2021-2026) & ($ millions)
Table 49. Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size by Region (2021-2026) & ($ millions)
Table 50. Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size by Type (2021-2026) & ($ millions)
Table 51. Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size by Application (2021-2026) & ($ millions)
Table 52. Key Market Drivers & Growth Opportunities of Amyotrophic Lateral Sclerosis Gene Testing
Table 53. Key Market Challenges & Risks of Amyotrophic Lateral Sclerosis Gene Testing
Table 54. Key Industry Trends of Amyotrophic Lateral Sclerosis Gene Testing
Table 55. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Forecast by Region (2027-2032) & ($ millions)
Table 56. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share Forecast by Region (2027-2032)
Table 57. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Forecast by Type (2027-2032) & ($ millions)
Table 58. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Forecast by Application (2027-2032) & ($ millions)
Table 59. Invitae Details, Company Type, Amyotrophic Lateral Sclerosis Gene Testing Area Served and Its Competitors
Table 60. Invitae Amyotrophic Lateral Sclerosis Gene Testing Product Offered
Table 61. Invitae Amyotrophic Lateral Sclerosis Gene Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 62. Invitae Main Business
Table 63. Invitae Latest Developments
Table 64. Quest Diagnostics Details, Company Type, Amyotrophic Lateral Sclerosis Gene Testing Area Served and Its Competitors
Table 65. Quest Diagnostics Amyotrophic Lateral Sclerosis Gene Testing Product Offered
Table 66. Quest Diagnostics Amyotrophic Lateral Sclerosis Gene Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. Quest Diagnostics Main Business
Table 68. Quest Diagnostics Latest Developments
Table 69. Labcorp Details, Company Type, Amyotrophic Lateral Sclerosis Gene Testing Area Served and Its Competitors
Table 70. Labcorp Amyotrophic Lateral Sclerosis Gene Testing Product Offered
Table 71. Labcorp Amyotrophic Lateral Sclerosis Gene Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. Labcorp Main Business
Table 73. Labcorp Latest Developments
Table 74. GeneDx Details, Company Type, Amyotrophic Lateral Sclerosis Gene Testing Area Served and Its Competitors
Table 75. GeneDx Amyotrophic Lateral Sclerosis Gene Testing Product Offered
Table 76. GeneDx Amyotrophic Lateral Sclerosis Gene Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. GeneDx Main Business
Table 78. GeneDx Latest Developments
Table 79. Centogene Details, Company Type, Amyotrophic Lateral Sclerosis Gene Testing Area Served and Its Competitors
Table 80. Centogene Amyotrophic Lateral Sclerosis Gene Testing Product Offered
Table 81. Centogene Amyotrophic Lateral Sclerosis Gene Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. Centogene Main Business
Table 83. Centogene Latest Developments
Table 84. Fulgent Genetics Details, Company Type, Amyotrophic Lateral Sclerosis Gene Testing Area Served and Its Competitors
Table 85. Fulgent Genetics Amyotrophic Lateral Sclerosis Gene Testing Product Offered
Table 86. Fulgent Genetics Amyotrophic Lateral Sclerosis Gene Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. Fulgent Genetics Main Business
Table 88. Fulgent Genetics Latest Developments
Table 89. Ambry Genetics Details, Company Type, Amyotrophic Lateral Sclerosis Gene Testing Area Served and Its Competitors
Table 90. Ambry Genetics Amyotrophic Lateral Sclerosis Gene Testing Product Offered
Table 91. Ambry Genetics Amyotrophic Lateral Sclerosis Gene Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. Ambry Genetics Main Business
Table 93. Ambry Genetics Latest Developments
Table 94. Baylor Genetics Details, Company Type, Amyotrophic Lateral Sclerosis Gene Testing Area Served and Its Competitors
Table 95. Baylor Genetics Amyotrophic Lateral Sclerosis Gene Testing Product Offered
Table 96. Baylor Genetics Amyotrophic Lateral Sclerosis Gene Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. Baylor Genetics Main Business
Table 98. Baylor Genetics Latest Developments
Table 99. Mayo Clinic Laboratories Details, Company Type, Amyotrophic Lateral Sclerosis Gene Testing Area Served and Its Competitors
Table 100. Mayo Clinic Laboratories Amyotrophic Lateral Sclerosis Gene Testing Product Offered
Table 101. Mayo Clinic Laboratories Amyotrophic Lateral Sclerosis Gene Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 102. Mayo Clinic Laboratories Main Business
Table 103. Mayo Clinic Laboratories Latest Developments
Table 104. NEALS Consortium Labs Details, Company Type, Amyotrophic Lateral Sclerosis Gene Testing Area Served and Its Competitors
Table 105. NEALS Consortium Labs Amyotrophic Lateral Sclerosis Gene Testing Product Offered
Table 106. NEALS Consortium Labs Amyotrophic Lateral Sclerosis Gene Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 107. NEALS Consortium Labs Main Business
Table 108. NEALS Consortium Labs Latest Developments
LIST OF FIGURES
Figure 1. Amyotrophic Lateral Sclerosis Gene Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Amyotrophic Lateral Sclerosis Gene Testing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Amyotrophic Lateral Sclerosis Gene Testing Sales Market Share by Country/Region (2025)
Figure 8. Amyotrophic Lateral Sclerosis Gene Testing Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Type in 2025
Figure 10. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Product Type in 2025
Figure 11. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Sample in 2025
Figure 12. Amyotrophic Lateral Sclerosis Gene Testing in Hospitals
Figure 13. Global Amyotrophic Lateral Sclerosis Gene Testing Market: Hospitals (2021-2026) & ($ millions)
Figure 14. Amyotrophic Lateral Sclerosis Gene Testing in Third-party Laboratory
Figure 15. Global Amyotrophic Lateral Sclerosis Gene Testing Market: Third-party Laboratory (2021-2026) & ($ millions)
Figure 16. Amyotrophic Lateral Sclerosis Gene Testing in Others
Figure 17. Global Amyotrophic Lateral Sclerosis Gene Testing Market: Others (2021-2026) & ($ millions)
Figure 18. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Application in 2025
Figure 19. Global Amyotrophic Lateral Sclerosis Gene Testing Revenue Market Share by Player in 2025
Figure 20. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Region (2021-2026)
Figure 21. Americas Amyotrophic Lateral Sclerosis Gene Testing Market Size 2021-2026 ($ millions)
Figure 22. APAC Amyotrophic Lateral Sclerosis Gene Testing Market Size 2021-2026 ($ millions)
Figure 23. Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size 2021-2026 ($ millions)
Figure 25. Americas Amyotrophic Lateral Sclerosis Gene Testing Value Market Share by Country in 2025
Figure 26. United States Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Region in 2025
Figure 31. APAC Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Type (2021-2026)
Figure 32. APAC Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Application (2021-2026)
Figure 33. China Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 37. India Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Country in 2025
Figure 40. Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Type (2021-2026)
Figure 41. Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Application (2021-2026)
Figure 42. Germany Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 43. France Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 56. APAC Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 57. Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 59. United States Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 60. Canada Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 61. Mexico Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 62. Brazil Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 63. China Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 64. Japan Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 65. Korea Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 67. India Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 68. Australia Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 69. Germany Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 70. France Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 71. UK Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 72. Italy Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 73. Russia Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 74. Egypt Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 75. South Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 76. Israel Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 77. Turkey Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 78. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 1. Amyotrophic Lateral Sclerosis Gene Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Amyotrophic Lateral Sclerosis Gene Testing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Amyotrophic Lateral Sclerosis Gene Testing Sales Market Share by Country/Region (2025)
Figure 8. Amyotrophic Lateral Sclerosis Gene Testing Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Type in 2025
Figure 10. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Product Type in 2025
Figure 11. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Sample in 2025
Figure 12. Amyotrophic Lateral Sclerosis Gene Testing in Hospitals
Figure 13. Global Amyotrophic Lateral Sclerosis Gene Testing Market: Hospitals (2021-2026) & ($ millions)
Figure 14. Amyotrophic Lateral Sclerosis Gene Testing in Third-party Laboratory
Figure 15. Global Amyotrophic Lateral Sclerosis Gene Testing Market: Third-party Laboratory (2021-2026) & ($ millions)
Figure 16. Amyotrophic Lateral Sclerosis Gene Testing in Others
Figure 17. Global Amyotrophic Lateral Sclerosis Gene Testing Market: Others (2021-2026) & ($ millions)
Figure 18. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Application in 2025
Figure 19. Global Amyotrophic Lateral Sclerosis Gene Testing Revenue Market Share by Player in 2025
Figure 20. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Region (2021-2026)
Figure 21. Americas Amyotrophic Lateral Sclerosis Gene Testing Market Size 2021-2026 ($ millions)
Figure 22. APAC Amyotrophic Lateral Sclerosis Gene Testing Market Size 2021-2026 ($ millions)
Figure 23. Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size 2021-2026 ($ millions)
Figure 25. Americas Amyotrophic Lateral Sclerosis Gene Testing Value Market Share by Country in 2025
Figure 26. United States Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Region in 2025
Figure 31. APAC Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Type (2021-2026)
Figure 32. APAC Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Application (2021-2026)
Figure 33. China Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 37. India Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Country in 2025
Figure 40. Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Type (2021-2026)
Figure 41. Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Application (2021-2026)
Figure 42. Germany Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 43. France Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 56. APAC Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 57. Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 59. United States Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 60. Canada Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 61. Mexico Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 62. Brazil Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 63. China Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 64. Japan Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 65. Korea Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 67. India Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 68. Australia Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 69. Germany Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 70. France Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 71. UK Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 72. Italy Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 73. Russia Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 74. Egypt Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 75. South Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 76. Israel Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 77. Turkey Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
Figure 78. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Amyotrophic Lateral Sclerosis Gene Testing Market Size 2027-2032 ($ millions)
